VRPX

Virpax Pharmaceuticals, Inc. Common Stock

Delisted

VRPX was delisted on the 3rd of April, 2025.

14 hedge funds and large institutions have $874K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$182

Top Sellers

1 -$225K
2 -$88.2K
3 -$9.09K
4
E
Ergoteles
New York
-$7.89K
5
UBS Group
UBS Group
Switzerland
-$7.35K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$551K
2
$79.2K
3
$75K
4
$51.6K
5
$51.1K
6
$14.9K
7
$13.4K
8
$13K
9
$11.9K
10
$7.85K
11
$4K
12
$471
13
$364
14
$118
15
$97
16
$47
17
18
19
20